Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IDO2 antibody

This Mouse Monoclonal antibody specifically detects IDO2 in WB, ELISA and FM. It exhibits reactivity toward Mouse and has been mentioned in 2+ publications.
Rockland
Catalog No. ABIN1043821
Supplier Product No.: 210-301-e59

Quick Overview for IDO2 antibody (ABIN1043821)

Target

See all IDO2 Antibodies
IDO2 (Indoleamine 2,3-Dioxygenase 2 (IDO2))

Reactivity

  • 55
  • 12
  • 11
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Mouse

Host

  • 63
  • 6
  • 1
Mouse

Clonality

  • 64
  • 6
Monoclonal

Conjugate

  • 32
  • 11
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IDO2 antibody is un-conjugated

Application

  • 59
  • 25
  • 21
  • 13
  • 13
  • 11
  • 8
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Fluorescence Microscopy (FM)

Clone

1HC
  • Supplier Product No.

    210-301-e59

    Supplier

    Rockland

    Purpose

    IDO2 Antibody

    Cross-Reactivity (Details)

    IDO2 antibody is specific for mouse IDO2 protein.

    Characteristics

    Synonyms: mouse anti-IDO2 Antibody, Indoleamine 2,3-dioxygenase 2, Indol1, Indoleamine 2,3-dioxygenase-like protein 1, Indoleamine-pyrrole 2,3-dioxygenase-like protein 1, Ido-2, Ido 2, IDO2 antibody, mouse anti-IDO-2 antibody

    Purification

    Anti-IDO2 was purified from concentrated tissue culture supernate by Protein G chromatography followed by extensive dialysis against the buffer stated above.

    Sterility

    Sterile filtered

    Immunogen

    Immunogen: Anti-IDO2 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with complete mouse IDO2 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Isotype

    IgG2a kappa
  • Application Notes

    Application Note: Anti-IDO2 antibody has been tested in western blot and is suitable for use in ELISA and IF. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    ELISA Dilution: 1:5000 - 1:50000

    IF Microscopy Dilution: 1:50-1:100

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.0 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Expiry Date

    12 months
  • Wolff, Driever, Erdlenbruch, Kortmann, Rutkowski, Pietsch, Parker, Metz, Gnekow, Kramm: "Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol." in: Cancer, Vol. 116, Issue 3, pp. 705-12, (2010) (PubMed).

    Metz, Duhadaway, Rust, Munn, Muller, Mautino, Prendergast: "Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase." in: Molecular cancer therapeutics, Vol. 9, Issue 6, pp. 1864-71, (2010) (PubMed).

  • Target

    IDO2 (Indoleamine 2,3-Dioxygenase 2 (IDO2))

    Alternative Name

    Ido2

    Background

    Background: Indoleamine 2,3-dioxygenase 2 (IDO2) is related to IDO1, and may play a role in T and B Cell Immunity. IDO2's role in immune regulation will be become clearer following the completion of genetic knock-out studies. IDO2 is expressed in a few select cell types and levels of protein expression appear to be very low, perhaps below the level of detection by IHC. Small-molecule inhibitors of indoleamine 2,3-dioxygenase (IDO) are currently being translated to clinic for evaluation as cancer therapeutics.

    Gene ID

    209176

    NCBI Accession

    NP_666061

    UniProt

    Q8R0V5
You are here:
Chat with us!